Last reviewed · How we verify
Relmacabtagene Autoleucel Injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Relmacabtagene Autoleucel Injection (Relmacabtagene Autoleucel Injection) — Changhai Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Relmacabtagene Autoleucel Injection TARGET | Relmacabtagene Autoleucel Injection | Changhai Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Relmacabtagene Autoleucel Injection CI watch — RSS
- Relmacabtagene Autoleucel Injection CI watch — Atom
- Relmacabtagene Autoleucel Injection CI watch — JSON
- Relmacabtagene Autoleucel Injection alone — RSS
Cite this brief
Drug Landscape (2026). Relmacabtagene Autoleucel Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/relmacabtagene-autoleucel-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab